How long should I take diammonium glycyrrhizinate enteric-coated capsules before stopping the medication?

Diammonium Glycyrrhizinate Enteric-coated Capsules do not have a fixed standard for discontinuation time. The decision should be made based on the purpose of medication, disease recovery progress, and individual tolerance. The key principle is to gradually adjust under medical guidance—never discontinue the drug on your own. Specific considerations are as follows:

This medication is commonly used to treat acute and chronic viral hepatitis accompanied by elevated alanine aminotransferase (ALT) levels, with treatment duration varying according to the condition. For patients with acute hepatitis, if liver function indicators recover quickly, after 4–8 weeks of treatment, the drug may be tapered off under a doctor’s supervision upon confirmation of stable and normal test results. Patients with chronic hepatitis usually require longer treatment courses—typically 3–6 months or even longer—and the timing of discontinuation should be determined based on regular follow-up evaluations of liver inflammation improvement.

Treatment efficacy and patient tolerance also influence the timing of discontinuation. Some patients may experience significant reduction in transaminase levels and symptom relief; however, if side effects such as elevated blood pressure or sodium and water retention occur, dosage adjustments or alternative medications may be needed earlier.

During treatment, it is essential to strictly follow medical instructions, undergo regular monitoring of liver function and electrolytes, and proactively report physical conditions to the physician. Maintaining a light diet, regular作息 (daily routine), avoiding alcohol consumption, and staying up late will help create favorable conditions for liver recovery.